Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Healthy Individuals H

31 de agosto de 2026 actualizado por: Silvia Ulrich Somaini

Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes

To study the effect of descent from high altitude (Quito Ecuador: 2850m) to sea level on six-minute walking distance and scores in healthy individuals, who live permanently >2600m.

Descripción general del estudio

Descripción detallada

The aim of this research is to investigate the six-minute walking distance and scores before and after descent (high altitude near their living altitude vs. sea level) in healthy individuals, who permanently live at high altitude over 2600m.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

14

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Silvia Ulrich, Prof. Dr. med.
  • Número de teléfono: +41442552220
  • Correo electrónico: silvia.ulrich@usz.ch

Copia de seguridad de contactos de estudio

  • Nombre: Michael Furian, Prof. Dr. sc. ETH
  • Número de teléfono: +41442552220

Ubicaciones de estudio

      • Zurich, Suiza, 8091
        • University Hospital of Zurich

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Adults aged 18-80 years and of all genders
  • Permanent residence > 2600 m
  • healthy: no self-perceived cardiopulmonary disease limiting daily activities
  • written informed consent to participate in the study

Exclusion Criteria:

  • Age <18 years or >80 years
  • Participants who cannot follow the study investigations
  • Participants permanently living < 2600m
  • Participants who traveled and stayed overnight at altitudes <2000 m in the past 4 weeks.
  • any self-perceived cardiopulmonary disease limiting daily activities

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Six-minute walking distance 6MWD at sea level
Assessment of the six-minute walking distance and scores near their resident altitude at 2850m followed by a descent from 2850m to sea level by bus with a stay for 7 days and again assessment of the same outcomes
Descent from 2850m to sea level with stay for 7 days

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Six-minute walking distance after 7 days at sea level
Periodo de tiempo: From high altitude (2850m) to day 5-7 at sea level
Difference/change in six-minute walking distance in meter (6MWD) between 2850m and Day 5-7 at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
SpO2 (%) at rest and end-exercise after 7 days at sea level
Periodo de tiempo: From high altitude (2850m) to day 5-7 at sea level
Difference/change in SpO2 (peripheral oxygen saturation) at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
Heart rate (beats per minute) at rest and end-exercise after 7 days at sea level
Periodo de tiempo: From high altitude (2850m) to day 5-7 at sea level
Difference/change in heart rate at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
Blood pressure (mmHg) at rest and end-exercise after 7 days at sea level
Periodo de tiempo: From high altitude (2850m) to day 5-7 at sea level
Difference/change in blood pressure at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
Dyspnea and leg discomfort sensation after 7 days at sea level
Periodo de tiempo: From high altitude (2850m) to day 5-7 at sea level
Difference/change in dyspnea and leg discomfort sensation (assessed with BORG-CR10-Scale, Category Rating 0-10 with 10 being the most dyspnea/leg discomfort) at rest and end-exercise between 2850m and 5-7 days at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
NYHA functional class (1-4) after 7 days at sea level
Periodo de tiempo: From high altitude (2850m) to day 5-7 at sea level
Difference/change in NYHA functional class (New York Heart Association Class I-IV, IV being the worst) at rest and end-exercise between 2850m and 5-7 days at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
Quality of life after 7 days at sea level
Periodo de tiempo: From high altitude (2850m) to day 5-7 at sea level
Difference/change in quality of life score (EmPHasis-10: Score with 10 questions and 0-50 points, higher scores indicating poorer quality of life) between 2850m and 5-7 days at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
General well-being after 7 days at sea level
Periodo de tiempo: From high altitude (2850m) to Day 5-7 at sea level
Difference/change in general well-being (Visual Analog Scale 10cm: the higher, the worse) between 2850m and day 5-7 at sea level in healthy individuals
From high altitude (2850m) to Day 5-7 at sea level
Acclimatization-effect of six-minute walking distance (m) at sea level
Periodo de tiempo: From Day 2 to Day 5-7 at sea level
Difference/change in six-minute walking distance (6MWD) within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of SpO2 (%) at rest and end-exercise at sea level
Periodo de tiempo: From Day 2 to Day 5-7 at sea level
Difference/change in SpO2 (peripheral oxygen saturation) at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of heart rate (beats per minute) at rest and end-exercise at sea level
Periodo de tiempo: From Day 2 to Day 5-7 at sea level
Difference/change in heart rate at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of blood pressure (mmHg) at rest and end-exercise at sea level
Periodo de tiempo: From Day 2 to Day 5-7 at sea level
Difference/change in blood pressure at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of dyspnea and leg discomfort at sea level
Periodo de tiempo: From Day 2 to Day 5-7 at sea level
Difference/change in dyspnea and leg discomfort (assessed with BORG-CR10-Scale, Category Rating 0-10 with 10 being the most dyspnea/leg discomfort) at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of NYHA functional class (1-4) at sea level
Periodo de tiempo: From Day 2 to Day 5-7 at sea level
Difference/change in NYHA functional class (New York Heart Association Class I-IV, IV being the worst) at rest and end-exercise within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of Quality of Life at sea level
Periodo de tiempo: From Day 2 to Day 5-7 at sea level
Difference/change in quality of life (EmPHasis-10: Score with 10 questions and 0-50 points, higher scores indicating poorer quality of life) within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of general well-being at sea level
Periodo de tiempo: From Day 2 to Day 5-7 at sea level
Difference/change in general well-being (Visual Analog Scale 10cm: the higher, the worse) within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Silvia Ulrich, University Hospital Zurich, Departement of Pulmonology
  • Investigador principal: Rodrigo Hoyos, Hospital Carlos Andrade Marin of Quito, Ecuador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

25 de septiembre de 2026

Finalización primaria (Estimado)

4 de octubre de 2026

Finalización del estudio (Estimado)

31 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

17 de agosto de 2026

Primero enviado que cumplió con los criterios de control de calidad

31 de agosto de 2026

Publicado por primera vez (Actual)

3 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

3 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

31 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Data will be provided upon request and based on a clear intention reviewed by an ethical review board.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir